Rosenberg, Gary A.

National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 1,722

Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat

Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism

Barrier Structure and Function StudiesProtease and Inhibitor Mechanisms

Cited by 1,060

Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat Brain

Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke

Barrier Structure and Function StudiesProtease and Inhibitor Mechanisms

Cited by 861

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

Rosenberg, G. A. (2009) · The Lancet Neurology

Protease and Inhibitor MechanismsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 594

Strategies to advance translational research into brain barriers

Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology

Barrier Structure and Function StudiesDrug Transport and Resistance Mechanisms

Cited by 474

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures

Rosenberg, G. A., Cunningham, L. A., Wallace, J., Alexander, S., Estrada, E. Y., Grossetete, M., Razhagi, A., Miller, K., & Gearing, A. (2001) · Brain Research

Protease and Inhibitor MechanismsBarrier Structure and Function Studies

Cited by 388

Ischemic brain edema

Rosenberg, G. A. (1999) · Progress in Cardiovascular Diseases

Acute Ischemic Stroke ManagementBarrier Structure and Function Studies

Cited by 278

Blood-brain barrier permeability abnormalities in vascular cognitive impairment

Taheri, S., Gasparovic, C., Huisa, B. N., Adair, J. C., Edmonds, E., Prestopnik, J., Grossetete, M., Shah, N. J., Wills, J., Qualls, C., et al. (2011) · Stroke

Barrier Structure and Function StudiesNeurological Disease Mechanisms and Treatments

Cited by 248

Matrix metalloproteinases as therapeutic targets for stroke

Yang, Y., & Rosenberg, G. A. (2015) · Brain Research

Protease and Inhibitor MechanismsAcute Ischemic Stroke Management

Cited by 246

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

Lukes, A., Mun-Bryce, S., Lukes, M., & Rosenberg, G. A. (1999) · Molecular Neurobiology

Protease and Inhibitor MechanismsBlood Coagulation and Thrombosis Mechanisms

Cited by 230

Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions

Rosenberg, G. A., Kyner, W. T., & Estrada, E. (1980) · American Journal of Physiology-Renal Physiology

Cerebrospinal fluid and hydrocephalusIon Transport and Channel Regulation

Cited by 210

White matter damage is associated with matrix metalloproteinases in vascular dementia

Rosenberg, G. A., Sullivan, N., & Esiri, M. M. (2001) · Stroke

Neurological Disease Mechanisms and TreatmentsCerebrovascular and genetic disorders

Cited by 207

Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment

Candelario-Jalil, E., Thompson, J., Taheri, S., Grossetete, M., Adair, J. C., Edmonds, E., Prestopnik, J., Wills, J., & Rosenberg, G. A. (2011) · Stroke

Neurological Disease Mechanisms and TreatmentsBarrier Structure and Function Studies

Cited by 173

Inflammation and white matter damage in vascular cognitive impairment

Rosenberg, G. A. (2009) · Stroke

Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments

Cited by 149

Early Inhibition of MMP Activity in Ischemic Rat Brain Promotes Expression of Tight Junction Proteins and Angiogenesis During Recovery

Yang, Y., Thompson, J. F., Taheri, S., Salayandia, V. M., McAvoy, T. A., Hill, J. W., Yang, Y., Estrada, E. Y., & Rosenberg, G. A. (2013) · Journal of Cerebral Blood Flow & Metabolism

Barrier Structure and Function StudiesAcute Ischemic Stroke Management

Cited by 147

Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway

Jiang, S., Maphis, N. M., Binder, J., Chisholm, D., Weston, L., Duran, W., Peterson, C., Zimmerman, A., Mandell, M. A., Jett, S. D., et al. (2021) · Cell Reports

Alzheimer's disease research and treatmentsInflammasome and immune disorders

Cited by 92

Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction

Raz, L., Bhaskar, K., Weaver, J., Marini, S., Zhang, Q., Thompson, J. F., Espinoza, C., Iqbal, S., Maphis, N. M., Weston, L., et al. (2019) · Neurobiology of Disease

Neurological Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 84

Magnetic resonance lipid signals in rat brain after experimental stroke correlate with neutral lipid accumulation

Gasparovic, C., Rosenberg, G. A., Wallace, J. A., Estrada, E. Y., Roberts, K., Pastuszyn, A., Ahmed, W., & Graham, G. D. (2001) · Neuroscience Letters

Advanced MRI Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Cited by 67

In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology

Torso, M., Ridgway, G. R., Valotti, M., Hardingham, I., Chance, S. A., for the National Alzheimer’s Coordinating Center, Brewer, J., Lopez, O., Hyman, B., Grabowski, T., et al. (2023) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications

Cited by 16